Cargando…

Anti-integrin therapy for inflammatory bowel disease

In inflammatory bowel disease (IBD), tumor necrosis factor plays an important role in mediating inflammation, but several other pathways are also involved in eliciting an inflammatory response. One such pathway is the invasion of the intestinal mucosa by leukocytes. Leukocytes within the systemic ci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sung Chul, Jeen, Yoon Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937204/ https://www.ncbi.nlm.nih.gov/pubmed/29740202 http://dx.doi.org/10.3748/wjg.v24.i17.1868

Ejemplares similares

Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017)

The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016)

Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
por: Park, Sung Chul, et al.
Publicado: (2019)

Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease
por: Dailey, Francis E, et al.
Publicado: (2018)

Inflammatory bowel disease and airway diseases
por: Vutcovici, Maria, et al.
Publicado: (2016)

Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
por: McCormack, Matthew D, et al.
Publicado: (2023)

Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
por: Crispino, Federica, et al.
Publicado: (2023)

Biosimilars in paediatric inflammatory bowel disease
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2018)

Food as Treatment of Inflammatory Bowel Diseases
por: Maldonado-Contreras, Ana
Publicado: (2022)

Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
por: Dubois-Camacho, Karen, et al.
Publicado: (2017)

Necroptosis in inflammatory bowel disease and other intestinal diseases
por: Li, Sha, et al.
Publicado: (2018)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Enteroscopy in children and adults with inflammatory bowel disease
por: Di Nardo, Giovanni, et al.
Publicado: (2020)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

Role of diet and nutrition in inflammatory bowel disease
por: de Castro, Marina Moreira, et al.
Publicado: (2021)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
por: Lashgari, Naser-Aldin, et al.
Publicado: (2021)

Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology
por: Malinauskiene, Vaidota, et al.
Publicado: (2023)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Potential role of nutraceutical compounds in inflammatory bowel disease
por: Larussa, Tiziana, et al.
Publicado: (2017)

Sexual health and fertility for individuals with inflammatory bowel disease
por: Leenhardt, Romain, et al.
Publicado: (2019)

Emerging use of artificial intelligence in inflammatory bowel disease
por: Kohli, Arushi, et al.
Publicado: (2020)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Application of single-cell omics in inflammatory bowel disease
por: Zheng, Hengqi Betty
Publicado: (2023)

Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment
por: Spiceland, Clayton M, et al.
Publicado: (2018)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease
por: Shukla, Richa, et al.
Publicado: (2017)

Treating children with inflammatory bowel disease: Current and new perspectives
por: Guariso, Graziella, et al.
Publicado: (2017)

Effect of inflammatory bowel disease treatments on patients with diabetes mellitus
por: Bower, Joshua Ashley Jack, et al.
Publicado: (2021)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Liver manifestations and complications in inflammatory bowel disease: A review
por: Gaspar, Rui, et al.
Publicado: (2021)

Shared decision-making in the management of patients with inflammatory bowel disease
por: Song, Kai, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Pregnancy and medications for inflammatory bowel disease: An updated narrative review
por: Akiyama, Shintaro, et al.
Publicado: (2023)

Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
por: Dotan, Iris, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49g7gj1egjj50aubuvsgtffu33